Author: OurCrowd

[Medisafe in Medisafe] Medisafe announces launch of GOMEKLI™ Digital Companion to support patients with NF1-PN Taking GOMEKLI

May 13, 2025 |

BOSTON, MA / May 13, 2025 / Medisafe, the leading digital health platform for medication engagement, today announced a collaboration with SpringWorks Therapeutics to launch the GOMEKLI™ (mirdametinib) Digital Companion by Medisafe—an innovative, behaviorally driven platform designed to support GOMEKLI patients living with neurofibromatosis type 1 (NF1) and symptomatic, inoperable plexiform neurofibromas (NF1-PN). Read...

Read More

[Alpha Tau in Globe Newswire] Alpha Tau announces appointment of Nadav Kidron to its Board of Directors

May 12, 2025 |

JERUSALEM, May 12, 2025 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) (“Alpha Tau” or the “Company”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, announced today that Mr. Nadav Kidron, the President, CEO, and Chairman of the Board of Oramed Pharmaceuticals Inc., (“Oramed”), has been appointed to the Company’s Board of Directors (“Board”). The appointment follows the recent closing of a strategic investment between the Company and an affiliate of Oramed. Read...

Read More

[Classiq in Globe Newswire] Classiq raises $110M in largest-ever quantum software funding round

May 12, 2025 | ,

TEL AVIV, Israel, May 12, 2025 (GLOBE NEWSWIRE) —  Classiq today announced raising $110 million in Series C funding, the largest ever for a quantum software company. The round was led by Entrée Capital, with participation from Norwest, NightDragon, funds managed by Hamilton Lane (Nasdaq: HLNE), Clal, Neva SGR, Phoenix, Team8, IN Venture, Wing, HSBC, Samsung Next and QBeat, as well as other new and existing investors. Read more...

Read More